ストックスクリーナーアプリを入手
0.73
2.96%
0.021
前日終値:
$0.709
開ける：
$0.7303
24時間の取引高:
42,033
Relative Volume:
0.26
時価総額：
$2.66M
収益：
$2.28M
当期純損益:
$-3.71M
株価収益率:
-0.2173
EPS:
-3.36
ネットキャッシュフロー:
$-3.60M
1週間 パフォーマンス:
+19.67%
1か月 パフォーマンス:
+33.70%
6か月 パフォーマンス:
-5.93%
1年 パフォーマンス:
-46.72%
1日の値動き範囲:
$0.7108
$0.7494
1週間の範囲:
$0.61
$0.7494
52週間の値動き範囲:
$0.4575
$1.52
Nanovibronix Inc Stock (NAOV) Company Profile
NAOV を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
NAOV
Nanovibronix Inc
|
0.73 | 2.66M | 2.28M | -3.71M | -3.60M | -3.36 |
|
ABT
Abbott Laboratories
|
118.95 | 208.18B | 41.22B | 5.77B | 6.49B | 2.94 |
|
SYK
Stryker Corp
|
388.14 | 148.70B | 21.97B | 3.59B | 3.21B | 6.74 |
|
BSX
Boston Scientific Corp
|
90.75 | 133.32B | 15.91B | 1.79B | 1.89B | 0.82 |
|
MDT
Medtronic Plc
|
86.27 | 111.27B | 33.00B | 4.29B | 5.50B | 2.71 |
|
EW
Edwards Lifesciences Corp
|
72.07 | 42.66B | 6.60B | 4.16B | 490.10M | 2.34 |
Nanovibronix Inc (NAOV) 最新ニュース
NanoVibronix Faces Potential Delisting from Nasdaq Due to Non-Compliance - Defense World
NanoVibronix faces potential Nasdaq delisting - Investing.com
NanoVibronix faces potential Nasdaq delisting By Investing.com - Investing.com UK
NanoVibronix Third Quarter 2024 Earnings: US$0.36 loss per share (vs US$0.42 loss in 3Q 2023) - Yahoo Finance
Armistice Capital, LLC Expands Stake in NanoVibronix Inc - GuruFocus.com
NanoVibronix Inc (NAOV) Quarterly 10-Q Report - Quartzy
NanoVibronix expands global reach, eyes new markets By Investing.com - Investing.com South Africa
NanoVibronix expands global reach, eyes new markets - Investing.com
NanoVibronix Expands Global Reach with NHS Approval, South African Distribution Deal | NAOV Stock News - StockTitan
A look into NanoVibronix Inc (NAOV)’s deeper side - SETE News
Ratios in Focus: Analyzing NanoVibronix Inc (NAOV)’s Price-to-Cash and Price-to-Free Cash Flow - The Dwinnex
NanoVibronix Inc (NAOV) Stock: A Year of Highs and Lows in the Market - The InvestChronicle
NanoVibronix Forges Potential New Distribution Deal - MPO-mag
NanoVibronix Takes Next Step to Partner with Specialist Urology Company to Expand Sales of UroShield in Germany - StockTitan
NanoVibronix stock hits 52-week low at $0.52 - Investing.com India
NanoVibronix stock hits 52-week low at $0.52 By Investing.com - Investing.com Canada
NanoVibronix extends CEO and CFO contracts with new terms - Investing.com India
NanoVibronix Secures Leadership with New Executive Agreements - TipRanks
NanoVibronix explores UroShield distribution in Israel By Investing.com - Investing.com Australia
NanoVibronix explores UroShield distribution in Israel - Investing.com
NAOVNanoVibronix, Inc. Latest Stock News & Market Updates - StockTitan
NanoVibronix Signs Letter of Intent with Potential New Distributor - StockTitan
Novo Nordisk and NanoVation to develop genetic medicines in partnership worth $600m - PMLiVE
Audit raises transparency concerns in IPO utilisation - The Business Post
UBC’s NanoVation Therapeutics inks US$600 million deal with Novo Nordisk - BCBusiness
Novo Nordisk and NanoVation Inked $600M+ Genetic Medicine Deal - Inside Precision Medicine
NanoVation partners with Novo Nordisk to develop genetic medicines - World Pharmaceutical Frontiers
Vancouver biotech inks $800M partnership with Novo Nordisk - Business in Vancouver
NanoVation inks genetic medicines deal with Novo Nordisk - The Pharma Letter
Novo Nordisk bets $600M biobucks on NanoVation's ability to take genetic medicines beyond the liver - Fierce Biotech
NanoVibronix (NASDAQ:NAOV) Stock Price Passes Below 50 Day Moving Average of $0.66 - Defense World
NanoVibronix (NASDAQ:NAOV) Stock Crosses Below 50-Day Moving Average of $0.70 - Defense World
NanoVibronix (STU:56R0) 5-Day RSI : 39.10 (As of Aug. 22, 2024) - GuruFocus.com
NanoVibronix (STU:56R0) Momentum Rank : 4 (As of Aug. 22, 2024) - GuruFocus.com
NanoVibronix (STU:56R0) Float Percentage Of Total Shares Ou - GuruFocus.com
NanoVibronix (STU:56R0) PE Ratio without NRI : At Loss (As of Aug. 22, 2024) - GuruFocus.com
NanoVibronix Highlights Second Quarter Revenue Growth and Narrowing of Loss from Operations in Letter to Stockholders - StockTitan
NAOV (NanoVibronix) Debt-to-Revenue : 0.03 (As of Mar. 2024) - GuruFocus.com
NAOV (NanoVibronix) EPS (Basic) : $-1.69 (TTM As of Mar. 2024) - GuruFocus.com
NanoVibronix Second Quarter 2024 Earnings: US$0.25 loss per share (vs US$0.65 loss in 2Q 2023) - Yahoo Finance
NanoVibronix (NASDAQ:NAOV) Stock Price Crosses Below 50 Day Moving Average of $0.72 - Defense World
NanoVibronix (STU:56R0) Short-Term Capital Lease Obligation : €0.04 Mil (As of Jun. 2024) - GuruFocus.com
NanoVibronix (NASDAQ:NAOV) Stock Passes Below Fifty Day Moving Average of $0.76 - Defense World
NanoVibronix stock hits 52-week low at $0.58 amid market challenges - Investing.com
NanoVibronix Inc (NAOV) Stock: Navigating Market Highs and Lows in 52 Weeks - The InvestChronicle
Financial Metrics Check: NanoVibronix Inc (NAOV)’s Ratios for Trailing Twelve Months - The Dwinnex
Short Interest in NanoVibronix, Inc. (NASDAQ:NAOV) Increases By 57.2% - Defense World
NanoVibronix (NASDAQ:NAOV) Share Price Crosses Below Fifty Day Moving Average of $0.76 - Defense World
Nanovibronix Inc (NAOV-Q) QuotePress Release - The Globe and Mail
NanoVibronix Announces Reverse Stock Split - Quantisnow
Nanovibronix Inc (NAOV) 財務データ
収益
当期純利益
現金流量
EPS
0.65%
大文字化:
|
ボリューム (24 時間):